Bigfoot Biomedical is a company known for optimizing insulin delivery. And recently, the company announced it raised $45 million in an initial tranche of a Series C equity financing.
Kyverna Therapeutics is a cell therapy company engineering a new class of therapies for serious autoimmune diseases, which recently raised $25 million.